Thursday, March 16, 2017

Rawls-Palmer Progress in Medicine Award Lecture
Analyzing text to extract information about gene-drug-disease interactions
Russ B. Altman, MD, PhD, Stanford University, Stanford, CA

SYMPOSIUM: Finding the Right Dose in the Right Patients for Oncology and Immunooncology: Are We There Yet and How Have Quantitative Pharmacology, Translational and Precision Medicine Been Utilized?
Chair: Yan Ji, PhD, Novartis Pharmaceuticals, East Hanover, NJ

Challenges and Opportunities for Modeling and simulation in Late Phase Oncology Development: Combinations, Cancer Immunotherapy, and More 
Jin Jin, PhD, Genentech, Inc., South San Franscisco, CA

Precision and Translational Medicine in Dose and Patient Selection in Oncology 
David Hyman, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Oncology Dose Finding for Small Molecules and Biologics: Perspective of the FDA-AACR Oncology Dose Finding Workshops
Geoffrey Kim, MD, US Food and Drug Administration, Silver Spring, MD

SYMPOSIUM: Using Biomarkers to Predict Registration Endpoints: A Look Inside the Crystal Ball
An Overview of Current Progress towards an Evidentiary Framework for Biomarker Qualification
John A. Wagner, MD, PhD, Takeda Pharmaceuticals International Co., Cambridge, MA

Role of Biomarkers and Quantitative Models in Drug Development
Yaning Wang, PhD, CDER, US Food and Drug Adminstration, Silver Spring, MD

Early Clinical Development Planning via Biomarkers, Clinical Endpoints, and Simulation: A Case Study to Optimize for Phase 3 Dose Selection
Bret Musser, PhD, Merck, Kenilworth, NJ

Linking Exploratory Clinical Development Endpoints to Phase 3 Endpoints: A Quantitative Basis for Decision-making
Richard Lalonde, PharmD, Pfizer, Groton, CT

Bridging the Gap Between Pharmacometricians and Statisticians in Clinical Pharmacology and Therapeutics
France Mentré, MD, PhD, University of Paris Diderot, Paris, France

WORKSHOP: Integrating Big Omics Data: Applications and Challenges
Antihypertensive Response and Precision Medicine: Novel Insights from Genomics and Metabolomics Integration
Mohamed Shahin, PhD, University of Florida, Gainesville, FL

Computational Approaches for Omics Data Integration 
Jianguo Xia, PhD, McGill University (Macdonald Campus), Quebec, Canada

ROUNDTABLE: Communicating Complex Information to Influence Decisions: What Works and What Doesn’t
Chair: Virginia (Ginny) Schmith, PhD, FCP, Nuventra Pharma Sciences, Durham, NC

Communication of Complex Information: Stakeholder Feedback
Norman Stockbridge, MD, PhD, US Food and Drug Administration, Silver Spring, MD

Communicating Complex Information in the Journal Anesthesiology
Michael Avram, PhD, Northwestern University Feinberg School of Medicine, Chicago, IL

Practical Tips for Communicating Complex Information and Analyses in Drug Development
Danny Howard, PhD, Novartis, East Hanover, NJ

Preparing our Future Leaders to be Effective Communicators
Kim L. R. Brouwer, PharmD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC

Martín J. Sepúlveda, MD, MPH, Retired, VP IBM Health Systems and Policy Research, IBM Research, Southbury, CT
Erin Moore, Eli Lilly and Company, Cincinnati, OH
Nick Dougherty, MassChallenge, Boston, MA

Photo Gallery
Recent News
Contact Us